Morphine to Hydromorphone: how to convert safely

Bottom line

1 mg oral morphine0.3 mg oral hydromorphone (MME factors 14). After converting, reduce the calculated dose by 25–50% for incomplete cross-tolerance and re-titrate to effect.

Worked example

  1. Total the 24-hour morphine dose — say 30 mg/day oral.
  2. Convert to morphine equivalents: 30 mg × 1 = 30 mg MME/day.
  3. Convert to hydromorphone: 30 ÷ 4 = 7.5 mg/day.
  4. Apply a 25–50% cross-tolerance reduction: start near 5.6 mg/day or lower, divided by the dosing interval, with breakthrough doses available.

Try it with your patient's numbers

01 · From

Current regimen

Normalized: 30.0 MME/day
24-hour MME bridge30.0MME/day

02 · To

Target regimen

Incomplete cross-tolerance reduction
03 · Estimated starting pointNo reduction applied
Hydromorphone 7.5 mg PO/day
30.0 mg/dayMorphine (PO)× 130.0 MMEnormalized÷ 47.5 mg/dayequianalgesic0%7.5 mg/daystarting estimate
Show calculation detail
1) Start: Morphine 30.0 mg PO/day
2) Convert to morphine equivalent: 30.0 mg × 1 → 30.0 mg MED/day
3) Convert to Hydromorphone (PO): 30.0 ÷ 4 → 7.5 mg/day
4) Cross-tolerance: 0%
→ Final conversion= 7.5 mg/day

Starting estimate, not a prescription. Round conservatively and reassess pain, sedation, organ function, interactions, and clinical trajectory before ordering.

Cautions specific to this switch

  • Active metabolites (M3G/M6G) accumulate in renal impairment — avoid or dose-reduce morphine when eGFR is reduced, and consider an alternative agent in dialysis patients.
  • Histamine release can cause pruritus and hypotension, which is not a true allergy but is often documented as one.
  • Hydromorphone is roughly 4–5× more potent than oral morphine mg-for-mg — dose-entry and unit errors with this drug are a recurring cause of serious opioid overdoses in hospitals.
  • Preferred over morphine in renal impairment (no clinically significant active metabolite accumulation at usual doses), but still start low in dialysis patients.
  • Equianalgesic tables are population averages. Re-assess pain, sedation (e.g. POSS), and respiratory status within hours of the first converted dose, not days.

Frequently asked questions

How much hydromorphone equals 30 mg of oral morphine per day?
30 mg/day of oral morphine is approximately 7.5 mg/day of oral hydromorphone (30 mg × 1 MME factor ÷ 4 = 7.5 mg), before any cross-tolerance reduction. Most patients switching opioids should start 25–50% below the calculated equianalgesic dose.
What is the conversion factor from morphine to hydromorphone?
Oral morphine has a morphine milligram equivalent (MME) factor of 1 and oral hydromorphone a factor of 4, so 1 mg of morphine ≈ 0.3 mg of hydromorphone. Equianalgesic tables are population averages — individual response varies, so titrate to effect.
Why reduce the dose for incomplete cross-tolerance?
Tolerance to one opioid does not fully transfer to another. When rotating from morphine to hydromorphone, standard practice is to reduce the calculated equianalgesic dose by 25–50% and provide breakthrough doses while re-titrating. Frail or elderly patients warrant the larger reduction.
Is this conversion exact?
No. Published equianalgesic factors are averages with wide interpatient variability, and they differ slightly between references. Treat the calculated dose as a starting estimate, apply a cross-tolerance reduction, and reassess pain and sedation frequently after the switch.

Creado y mantenido por Yasmine Abbey, MD, MSc · Última revisión:

Apoyo educativo a la decisión para profesionales sanitarios. No es consejo médico — verifique los resultados frente a su juicio clínico, los protocolos de su institución y las guías vigentes.